Spark Therapeutics CEO talks drug pricing, gene therapy & his Philadelphia roots. – Philadelphia Business Journal
San Francisco Business Times |
Spark Therapeutics CEO talks drug pricing, gene therapy & his Philadelphia roots.
Philadelphia Business Journal "We generally pay for more diagnostic tests, procedures, visits and prescriptions. And I think [patients] should be paying for better outcomes and not for more health care.” Subscribe to get the full story. Already a subscriber? Sign in. Subscribe to … Cell, gene therapies are hot. But can this startup make them safer? |
